These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3805329)

  • 1. Desipramine in the treatment of children with attention deficit disorder.
    Biederman J; Gastfriend DR; Jellinek MS
    J Clin Psychopharmacol; 1986 Dec; 6(6):359-63. PubMed ID: 3805329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of desipramine in children.
    Schroeder JS; Mullin AV; Elliott GR; Steiner H; Nichols M; Gordon A; Paulos M
    J Am Acad Child Adolesc Psychiatry; 1989 May; 28(3):376-9. PubMed ID: 2661525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and neuropsychological effects of desipramine in children with attention deficit hyperactivity disorder.
    Gualtieri CT; Keenan PA; Chandler M
    J Clin Psychopharmacol; 1991 Jun; 11(3):155-9. PubMed ID: 2066453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine in the treatment of adolescents with attention deficit disorder.
    Gastfriend DR; Biederman J; Jellinek MS
    Am J Psychiatry; 1984 Jul; 141(7):906-8. PubMed ID: 6375400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desipramine treatment of boys with attention-deficit hyperactivity disorder and tics: preliminary clinical experience.
    Riddle MA; Hardin MT; Cho SC; Woolston JL; Leckman JF
    J Am Acad Child Adolesc Psychiatry; 1988 Nov; 27(6):811-4. PubMed ID: 3198572
    [No Abstract]   [Full Text] [Related]  

  • 6. A naturalistic study of 24-hour electrocardiographic recordings and echocardiographic findings in children and adolescents treated with desipramine.
    Biederman J; Baldessarini RJ; Goldblatt A; Lapey KA; Doyle A; Hesslein PS
    J Am Acad Child Adolesc Psychiatry; 1993 Jul; 32(4):805-13. PubMed ID: 8340302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of hyperkinetic children taking methylphenidate, dextroamphetamine, or imipramine/desipramine.
    Millichap JG
    Pediatrics; 1978 Jan; 61(1):146-7. PubMed ID: 263851
    [No Abstract]   [Full Text] [Related]  

  • 8. Sudden death in children treated with a tricyclic antidepressant.
    Med Lett Drugs Ther; 1990 Jun; 32(819):53. PubMed ID: 2342435
    [No Abstract]   [Full Text] [Related]  

  • 9. Tourette's syndrome with symptoms of attention deficit disorder treated with desipramine.
    Linet LS
    J Clin Psychiatry; 1987 Nov; 48(11):456. PubMed ID: 3479424
    [No Abstract]   [Full Text] [Related]  

  • 10. Desipramine in the treatment of attention deficit disorder in adolescents.
    Gastfriend DR; Biederman J; Jellinek MS
    Psychopharmacol Bull; 1985; 21(1):144-5. PubMed ID: 3983334
    [No Abstract]   [Full Text] [Related]  

  • 11. Possible influence of carbamazepine on plasma imipramine concentrations in children with attention deficit hyperactivity disorder.
    Brown CS; Wells BG; Cold JA; Froemming JH; Self TH; Jabbour JT
    J Clin Psychopharmacol; 1990 Oct; 10(5):359-62. PubMed ID: 2258453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
    Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
    Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of desipramine in children and adolescents with attention deficit disorder.
    Biederman J; Gastfriend D; Jellinek MS; Goldblatt A
    J Pediatr; 1985 Jun; 106(6):1017-20. PubMed ID: 3998940
    [No Abstract]   [Full Text] [Related]  

  • 15. Desipramine and cutaneous reactions in pediatric outpatients.
    Biederman J; Gonzalez E; Bronstein B; De Monaco H; Wright V
    J Clin Psychiatry; 1988 May; 49(5):178-83. PubMed ID: 2966797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medication for children with attention disorders.
    Colson ER
    Pediatrics; 1997 Jun; 99(6):922-3. PubMed ID: 9190559
    [No Abstract]   [Full Text] [Related]  

  • 17. Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children.
    Mosholder AD; Gelperin K; Hammad TA; Phelan K; Johann-Liang R
    Pediatrics; 2009 Feb; 123(2):611-6. PubMed ID: 19171629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression.
    ; Bangs ME; Emslie GJ; Spencer TJ; Ramsey JL; Carlson C; Bartky EJ; Busner J; Duesenberg DA; Harshawat P; Kaplan SL; Quintana H; Allen AJ; Sumner CR
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):407-20. PubMed ID: 17822337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
    Boellner SW; Earl CQ; Arora S
    Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.